Form 4 for GILD Gilead Sciences
Accepted 2026-06-16 18:02:08 ET · period of report 2026-06-15 · accession 0001782135-26-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-16 18:02 | 2026-06-15 | GILD | Mercier Johanna | Chief Comm, Corp Aff Off | S - Sale | $123.92 | -3,000 | 124.2K | -2% | -$371.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | S | D | 1,480 | $123.42 | 125,754 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. (F2) Sale prices for the transactions reported range from $122.79 to $123.785. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 2 | Common | Common Stock | 2026-06-15 | S | D | 1,070 | $124.00 | 124,684 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. (F3) Sale prices for the transactions reported range from $123.81 to $124.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| 3 | Common | Common Stock | 2026-06-15 | S | D | 450 | $125.40 | 124,234 | D | — | — | (F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. |